WO1998009597A3 - Cushioning beads and tablet comprising the same capable of forming a suspension - Google Patents
Cushioning beads and tablet comprising the same capable of forming a suspension Download PDFInfo
- Publication number
- WO1998009597A3 WO1998009597A3 PCT/US1997/015573 US9715573W WO9809597A3 WO 1998009597 A3 WO1998009597 A3 WO 1998009597A3 US 9715573 W US9715573 W US 9715573W WO 9809597 A3 WO9809597 A3 WO 9809597A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beads
- biologically active
- tablets
- active ingredient
- cushioning
- Prior art date
Links
- 239000011324 bead Substances 0.000 title abstract 7
- 239000000725 suspension Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 4
- 239000003826 tablet Substances 0.000 abstract 4
- 229920002785 Croscarmellose sodium Polymers 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229960001681 croscarmellose sodium Drugs 0.000 abstract 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 238000005563 spheronization Methods 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 230000009747 swallowing Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004565 water dispersible tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU41814/97A AU4181497A (en) | 1996-09-06 | 1997-09-04 | Cushioning beads and tablet comprising the same capable of forming a suspension |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/709,415 | 1996-09-06 | ||
US08/709,415 US5780055A (en) | 1996-09-06 | 1996-09-06 | Cushioning beads and tablet comprising the same capable of forming a suspension |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998009597A2 WO1998009597A2 (en) | 1998-03-12 |
WO1998009597A3 true WO1998009597A3 (en) | 2001-06-28 |
Family
ID=24849759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/015573 WO1998009597A2 (en) | 1996-09-06 | 1997-09-04 | Cushioning beads and tablet comprising the same capable of forming a suspension |
Country Status (3)
Country | Link |
---|---|
US (1) | US5780055A (en) |
AU (1) | AU4181497A (en) |
WO (1) | WO1998009597A2 (en) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138485A1 (en) * | 1998-01-14 | 2003-07-24 | Daiichi Pharmaceutical Co., Ltd. | Disintegrant |
US6365185B1 (en) * | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
AU4288599A (en) * | 1998-07-01 | 2000-01-24 | Sun Pharmaceutical Industries Ltd. | Stable pharmaceutical compositions of thieno (3,2-c) pyridine derivatives |
US6126967A (en) * | 1998-09-03 | 2000-10-03 | Ascent Pediatrics | Extended release acetaminophen particles |
US6254891B1 (en) * | 1998-09-03 | 2001-07-03 | Ascent Pediatrics, Inc. | Extended release acetaminophen |
US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
US6160165A (en) * | 1998-12-10 | 2000-12-12 | Aesgen, Inc. | Method for preparation of disodium pamidronate |
US6794536B1 (en) | 1998-12-10 | 2004-09-21 | Aesqen, Inc. | Method for preparation of disodium pamidronate |
US20090060995A1 (en) | 2005-01-13 | 2009-03-05 | Kamalinder Kaur Singh | Dispersible sustained release pharmaceutical compositions |
CA2360938C (en) * | 1999-02-02 | 2008-01-08 | Warren Oliver Haggard | Controlled release composite |
US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
EP1228125A4 (en) * | 1999-09-14 | 2009-09-02 | Smithkline Beecham Corp | Process for making aqueous coated beadlets |
GB9921933D0 (en) | 1999-09-17 | 1999-11-17 | Univ Gent | Solid shaped articles comprising biologically active substances and a method for their production |
KR100329685B1 (en) * | 1999-09-17 | 2002-03-25 | 강덕영 | Quick Dispersible Formulation with Acetaminophen Tablet and Its process |
DE10003757A1 (en) * | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen drug preparation |
IL151475A0 (en) * | 2000-03-30 | 2003-04-10 | Bristol Myers Squibb Co | Beadlets containing stavudine |
FR2807973B1 (en) | 2000-04-21 | 2002-11-15 | Filtrauto | VEHICLE INTERIOR AIR FILTER, VEHICLE COMPRISING SUCH A FILTER, AND MANUFACTURING METHOD |
US6623756B1 (en) * | 2000-04-27 | 2003-09-23 | Noveon Ip Holdings Corp. | Directly compressed solid dosage articles |
US6258343B1 (en) * | 2000-08-15 | 2001-07-10 | Colgate-Palmolive Company | Method for encapsulating reactive dental agents |
CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2830447B1 (en) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | MICROPARTICULAR ORAL GALENIC FORM FOR DELAYED AND CONTROLLED RELEASE OF PHARMACEUTICAL ACTIVE INGREDIENTS |
SE0103613D0 (en) * | 2001-10-30 | 2001-10-30 | Astrazeneca Ab | Novel formulation |
IL164221A0 (en) * | 2002-04-09 | 2005-12-18 | Flamel Tech Sa | Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim |
EP1492511B3 (en) | 2002-04-09 | 2012-05-02 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
US7125563B2 (en) * | 2002-04-12 | 2006-10-24 | Dava Pharmaceuticals, Inc. | Sustained release pharmaceutical preparations and methods for producing the same |
US6958161B2 (en) | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
WO2003091290A1 (en) * | 2002-04-23 | 2003-11-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for reduction of residual organic solvent in carbomer |
US20050020613A1 (en) * | 2002-09-20 | 2005-01-27 | Alpharma, Inc. | Sustained release opioid formulations and method of use |
FR2845289B1 (en) * | 2002-10-04 | 2004-12-03 | Ethypharm Sa | SPHEROIDS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS. |
WO2004060354A1 (en) * | 2002-12-31 | 2004-07-22 | Augsburger Larry L | Methods for making pharmaceutical dosage forms containing active cushioning components |
US20040161459A1 (en) * | 2002-12-31 | 2004-08-19 | Ngoc Do | Fast-dissolve tablet technology |
WO2004087175A1 (en) * | 2003-04-04 | 2004-10-14 | Pharmacia Corporation | Oral extended release compressed tablets of multiparticulates |
US6959588B2 (en) * | 2003-06-19 | 2005-11-01 | Schlumberger Technology Corporation | Couette device and method to study solids deposition from flowing fluids |
EP2112920B1 (en) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
CA2533150C (en) * | 2003-07-25 | 2013-03-12 | Warner Chilcott Company, Inc. | A doxycycline metal complex in a solid dosage form |
WO2005061088A1 (en) * | 2003-12-22 | 2005-07-07 | Finlay Warren H | Powder formation by atmospheric spray-freeze drying |
US7207505B2 (en) * | 2004-06-04 | 2007-04-24 | Bender Martin P | Method for producing small granules |
US20070224269A1 (en) * | 2004-06-10 | 2007-09-27 | Rubino Orapin P | Controlled Release Pharmaceutical Formulation |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
DE602005022462D1 (en) * | 2004-09-20 | 2010-09-02 | Ltb4 Sweden Ab | STABILIZED LEUKOTRIEN B4 (LTB4) PHARMACEUTICAL |
JP5235416B2 (en) * | 2005-01-21 | 2013-07-10 | ワーナー・チルコット・カンパニー・エルエルシー | Tetracycline metal complexes in solid dosage forms. |
US20060263429A1 (en) | 2005-05-20 | 2006-11-23 | Hengsheng Feng | Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof |
WO2006133733A1 (en) * | 2005-06-13 | 2006-12-21 | Flamel Technologies | Oral dosage form comprising an antimisuse system |
US8652529B2 (en) | 2005-11-10 | 2014-02-18 | Flamel Technologies | Anti-misuse microparticulate oral pharmaceutical form |
FR2892937B1 (en) * | 2005-11-10 | 2013-04-05 | Flamel Tech Sa | MICROPARTICULAR ORAL PHARMACEUTICAL FORM ANTI-MEASURING |
US8685478B2 (en) | 2005-11-21 | 2014-04-01 | Philip Morris Usa Inc. | Flavor pouch |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
CN101453993A (en) | 2006-04-03 | 2009-06-10 | 伊萨·奥迪迪 | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US8637076B2 (en) * | 2006-06-01 | 2014-01-28 | Cima Labs Inc. | Prednisolone salt formulations |
WO2008140772A2 (en) * | 2007-05-08 | 2008-11-20 | Hercules Incorporated | Robust rapid disintegration tablet formulation |
US8424541B2 (en) | 2007-07-16 | 2013-04-23 | Philip Morris Usa Inc. | Tobacco-free oral flavor delivery pouch product |
WO2009010881A2 (en) * | 2007-07-16 | 2009-01-22 | Philip Morris Products S.A. | Oral pouch products with immobilized flavorant particles |
KR101109633B1 (en) * | 2007-08-03 | 2012-01-31 | 제이더블유중외제약 주식회사 | Composition for manufacturing orally disintegrating dosage forms, for protecting the coating of active substance |
EP2203174A4 (en) * | 2007-09-19 | 2010-09-29 | Combinatorx Inc | Therapeutic regimens for the treatment of immunoinflammatory disorders |
WO2010017056A1 (en) * | 2008-08-07 | 2010-02-11 | Merck & Co., Inc. | Orally administered solid formulations containing a hydrophobic drug and tpgs |
DE102008048729A1 (en) * | 2008-09-24 | 2010-03-25 | Add Technologies Ltd Advanced Drug Delivery | Multiparticulate tablets and process for their preparation |
PL2378883T3 (en) * | 2008-12-04 | 2016-06-30 | Intec Pharma Ltd | Zaleplon gastroretentive drug delivery system |
US8747562B2 (en) * | 2009-10-09 | 2014-06-10 | Philip Morris Usa Inc. | Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release |
CA2781089C (en) * | 2009-11-19 | 2015-01-27 | Nippon Soda Co., Ltd. | Reduction treatment method for ballast water |
CN102762198A (en) * | 2010-05-15 | 2012-10-31 | 欢腾生命科学有限公司 | Multi-unit compositions |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
KR20130076015A (en) * | 2011-12-28 | 2013-07-08 | 주식회사 삼양바이오팜 | Highly robust fast disintegrating tablet and process for manufacturing the same |
EP2841057B1 (en) | 2012-04-25 | 2019-03-20 | SPI Pharma, INC. | Crystalline microspheres and the process for manufacturing the same |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
EP3043779B1 (en) | 2013-09-13 | 2018-05-16 | R.P. Scherer Technologies, LLC | Encased-pellet tablets |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
DK130287D0 (en) * | 1987-03-13 | 1987-03-13 | Benzon As Alfred | ORAL PREPARATION |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
US5643591A (en) * | 1991-01-16 | 1997-07-01 | Fmc Corporation | Solid dosage forms |
-
1996
- 1996-09-06 US US08/709,415 patent/US5780055A/en not_active Expired - Fee Related
-
1997
- 1997-09-04 AU AU41814/97A patent/AU4181497A/en not_active Abandoned
- 1997-09-04 WO PCT/US1997/015573 patent/WO1998009597A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
Also Published As
Publication number | Publication date |
---|---|
US5780055A (en) | 1998-07-14 |
AU4181497A (en) | 1998-03-26 |
WO1998009597A2 (en) | 1998-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998009597A3 (en) | Cushioning beads and tablet comprising the same capable of forming a suspension | |
WO2001089479A3 (en) | Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds | |
HUP0203451A2 (en) | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation | |
CA2285266A1 (en) | Extended release formulations of erythromycin derivatives | |
CA2282513A1 (en) | Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
FI20011852A (en) | A process for the preparation of a dispersible tablet containing fluoxetine or an acid addition salt thereof | |
WO2001082895A3 (en) | Guaifenesin sustained release formulation and tablets | |
WO2004010998A8 (en) | Sustained-release tablet comprising reboxetine | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
CA2322315A1 (en) | Fast disintegrating tablets | |
CA2321523A1 (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
IL219820A0 (en) | Hydrophilic controlled release formulation comprising pregelatinized starch for controlled release of an active component | |
BR0103033A (en) | Pharmaceutical particles of masked flavor | |
CA2330480A1 (en) | Controlled release formulation of divalproex sodium | |
AU2793989A (en) | Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained | |
WO1998038983A3 (en) | Swallow tablet comprising paracetamol | |
MXPA03008420A (en) | Solid orally-dispersible pharmaceutical formulation. | |
KR900004326A (en) | Dispersible tablets of dihydrogergotoxin and its acid addition salt | |
DE60018629D1 (en) | Carbamazepine formulation with delayed release | |
AP1595A (en) | Pharmaceutical formulation having a masked taste and method for the production thereof. | |
WO2001034118A3 (en) | Solid dispersion pharmaceutical formulations | |
UA89349C2 (en) | Uncoated tablet containing olanzapine and a process for preparing thereof | |
WO2002053149A3 (en) | Medicament containing a polyamine as an active substance | |
WO2001006982A3 (en) | Low-dose tablets and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998512894 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |